Skip to content

TIL - Instil Bio, Inc. - AlphaYou

Discover Compare Pricing

Sign in Sign up

Home Smart money Buy calls Analyze

Back to stock searchT

Instil Bio Inc.

TIL · NASDAQ

Save to watchlist

Price is syncing

Reported smart-money activity for this stock is still below.

T

TILInstil Bio Inc.

Overview

No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.

Key stats

Aug 21

52-wk high: $33.83
52-wk low: $5.67
Prev close: $20.53
Mkt cap: $50.1M
Beta: 1.91
P/S: 54248.8x

Smart money

6 funds hold a position.

Real smart money

Funds holding this stock

6 holders

Combined position$2.2M

MI
Millennium
Israel Englander · Q2 2026 13F
$1.0M
position
JS
Jim Simons
Q2 2026 13F

Earnings

Reported Aug 7, 2026

Earnings came in 80.0% below what analysts expected.

Documents

Quarterly report10-Q Annual report10-K

Financials

Fundamentals

Is the business strong?

This company is running thin margins.

Net margin: 0.0%
Market cap: $50M

Valuation

P/S54248.82
P/B0.47

Quality

Operating margin0.0%
ROE

Technicals

Technicals

Price structure

No data yet

Technicals sync when verified market data is available. No sample data is shown.

Company

Symbol: TIL
Exchange: NASDAQ
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Market cap: $50.12M
Beta: 1.91

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Research hubs
About
Editorial policy
Methodology
Source coverage
Corrections

Privacy
Terms
Refunds
Disclaimer

© 2026 AlphaYou. All rights reserved.Not financial advice. Do your own research. Informational data only; past performance does not predict future results.

P/B

0.5x

Profit margin

+0.0%

Op margin

+0.0%

ROE

-25.3%

$387K

position

CI

Citadel

Ken Griffin · Q2 2026 13F

$236K

position

3 more holders

Lite opens all of them for $16.50/month, paid yearly.

Unlock all 3 holders

Coverage gaps for TIL

No recent insider trade
No recent Congress trade
No recent market-voice mention

Earnings per share

-$0.63-80.0%

-$0.35 expected

Next report

What the street expects next

-25.3%

ROA-10.8%

Growth

Beta1.91